These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 18755270)
1. Quality by design - Spray drying of insulin intended for inhalation. Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270 [TBL] [Abstract][Full Text] [Related]
2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method. You Y; Zhao M; Liu G; Tang X J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186 [TBL] [Abstract][Full Text] [Related]
3. Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments. Nekkanti V; Muniyappan T; Karatgi P; Hari MS; Marella S; Pillai R Drug Dev Ind Pharm; 2009 Oct; 35(10):1219-29. PubMed ID: 19555246 [TBL] [Abstract][Full Text] [Related]
4. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Ståhl K; Claesson M; Lilliehorn P; Lindén H; Bäckström K Int J Pharm; 2002 Feb; 233(1-2):227-37. PubMed ID: 11897427 [TBL] [Abstract][Full Text] [Related]
5. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process. Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129 [TBL] [Abstract][Full Text] [Related]
6. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs. Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421 [TBL] [Abstract][Full Text] [Related]
7. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof. Maschke A; Becker C; Eyrich D; Kiermaier J; Blunk T; Göpferich A Eur J Pharm Biopharm; 2007 Feb; 65(2):175-87. PubMed ID: 17070025 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles. Kawakami K; Sumitani C; Yoshihashi Y; Yonemochi E; Terada K Int J Pharm; 2010 May; 390(2):250-9. PubMed ID: 20170721 [TBL] [Abstract][Full Text] [Related]
9. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation. Amaro MI; Tajber L; Corrigan OI; Healy AM Int J Pharm; 2011 Dec; 421(1):99-109. PubMed ID: 21963473 [TBL] [Abstract][Full Text] [Related]
10. Statistical modeling of protein spray drying at the lab scale. Prinn KB; Costantino HR; Tracy M AAPS PharmSciTech; 2002; 3(1):E4. PubMed ID: 12916957 [TBL] [Abstract][Full Text] [Related]
11. Design space approach in the optimization of the spray-drying process. Lebrun P; Krier F; Mantanus J; Grohganz H; Yang M; Rozet E; Boulanger B; Evrard B; Rantanen J; Hubert P Eur J Pharm Biopharm; 2012 Jan; 80(1):226-34. PubMed ID: 21983606 [TBL] [Abstract][Full Text] [Related]
12. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying. Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation. Burggraeve A; Van Den Kerkhof T; Hellings M; Remon JP; Vervaet C; De Beer T Eur J Pharm Biopharm; 2010 Sep; 76(1):138-46. PubMed ID: 20554021 [TBL] [Abstract][Full Text] [Related]
14. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Minne A; Boireau H; Horta MJ; Vanbever R Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052 [TBL] [Abstract][Full Text] [Related]
15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate. Thi TH; Danède F; Descamps M; Flament MP Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120 [TBL] [Abstract][Full Text] [Related]
16. Cyclone selection influences protein damage during drying in a mini spray-dryer. Bögelein J; Lee G Int J Pharm; 2010 Nov; 401(1-2):68-71. PubMed ID: 20887779 [TBL] [Abstract][Full Text] [Related]
17. Quality by design approach to understand the process of nanosuspension preparation. Verma S; Lan Y; Gokhale R; Burgess DJ Int J Pharm; 2009 Jul; 377(1-2):185-98. PubMed ID: 19446617 [TBL] [Abstract][Full Text] [Related]
18. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Lee SH; Heng D; Ng WK; Chan HK; Tan RB Int J Pharm; 2011 Jan; 403(1-2):192-200. PubMed ID: 20951781 [TBL] [Abstract][Full Text] [Related]
19. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments. Razuc M; Piña J; Ramírez-Rigo MV AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497 [TBL] [Abstract][Full Text] [Related]
20. Quality by design - Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation. Alhajj N; O'Reilly NJ; Cathcart H Int J Pharm; 2023 Jul; 642():123151. PubMed ID: 37364778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]